Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-10 2:31 pm Sale | 2023-06-30 | 13G | Altimmune, Inc. ALT | STATE STREET CORP STT | 804,073 1.630% | -5,110,515 (-86.41%) | Filing History |
| 2023-04-12 2:55 pm Unchanged | 2022-12-31 | 13G | Altimmune, Inc. ALT | TIAA CREF INVESTMENT MANAGEMENT LLC | 3,265,963 6.640% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Altimmune, Inc. ALT | TANG CAPITAL PARTNERS LP | 2,700,450 5.500% | 500,450 (+22.75%) | Filing History |
| 2023-02-14 3:49 pm Purchase | 2022-12-31 | 13G | Altimmune, Inc. ALT | Avidity Partners Management LP | 3,990,000 8.100% | 1,225,000 (+44.30%) | Filing History |
| 2023-02-14 3:07 pm Sale | 2022-12-31 | 13G | Altimmune, Inc. ALT | Cormorant Asset Management, LP | 2,600,000 5.290% | -400,000 (-13.33%) | Filing History |
| 2023-02-14 08:46 am Purchase | 2022-12-31 | 13G | Altimmune, Inc. ALT | TIAA CREF INVESTMENT MANAGEMENT LLC | 3,265,963 7.560% | 1,056,159 (+47.79%) | Filing History |
| 2023-02-13 10:36 am Purchase | 2022-12-31 | 13G | Altimmune, Inc. ALT | JANUS HENDERSON GROUP PLC JHG | 3,833,579 7.800% | 3,833,579 (New Position) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Altimmune, Inc. ALT | The Vanguard Group | 2,532,420 5.150% | 2,532,420 (New Position) | Filing History |
| 2023-01-10 08:00 am Purchase | 2022-12-31 | 13G | Altimmune, Inc. ALT | STATE STREET CORP STT | 5,914,588 12.030% | 5,223,447 (+755.77%) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Altimmune, Inc. ALT | BlackRock Inc. BLK | 962,184 2.200% | -1,994,083 (-67.45%) | Filing History |
| 2022-07-07 4:01 pm Purchase | 2022-06-27 | 13G | Altimmune, Inc. ALT | Cormorant Asset Management, LP | 3,000,000 6.130% | 3,000,000 (New Position) | Filing History |
| 2022-04-11 1:42 pm Sale | 2022-03-31 | 13G | Altimmune, Inc. ALT | STATE STREET CORP STT | 691,141 1.600% | -3,730,400 (-84.37%) | Filing History |
| 2022-03-24 4:04 pm Purchase | 2022-03-14 | 13G | Altimmune, Inc. ALT | TANG CAPITAL PARTNERS LP | 2,200,000 5.100% | 2,200,000 (New Position) | Filing History |
| 2022-02-14 4:20 pm Sale | 2021-12-31 | 13G | Altimmune, Inc. ALT | Venrock Healthcare Capital Partners II, L.P. | 1,760,870 4.200% | -1,862,094 (-51.40%) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-12-31 | 13G | Altimmune, Inc. ALT | Baker Bros. Advisors LP | 1,941,604 4.800% | 57,153 (+3.03%) | Filing History |
| 2022-02-14 06:13 am Sale | 2021-12-31 | 13G | Altimmune, Inc. ALT | SPHERA FUNDS MANAGEMENT LTD. | 1,244,241 3.130% | -2,531,377 (-67.05%) | Filing History |
| 2022-02-11 2:38 pm Purchase | 2021-12-31 | 13G | Altimmune, Inc. ALT | Teachers Advisors LLC | 2,209,804 5.760% | 2,209,804 (New Position) | Filing History |
| 2022-02-11 2:37 pm Purchase | 2021-12-31 | 13G | Altimmune, Inc. ALT | TIAA CREF INVESTMENT MANAGEMENT LLC | 2,209,804 5.760% | 2,209,804 (New Position) | Filing History |
| 2022-02-11 07:38 am Purchase | 2021-12-31 | 13G | Altimmune, Inc. ALT | STATE STREET CORP STT | 4,421,541 11.130% | 430,400 (+10.78%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Altimmune, Inc. ALT | BlackRock Inc. BLK | 2,956,267 7.400% | 2,956,267 (New Position) | Filing History |